Phase II study of induction gemcitabine and S-1 followed by chemoradiotherapy and systemic chemotherapy using S-1 for locally advanced pancreatic cancer

被引：0
|
作者：
Kentaro Sudo
Ryusuke Hara
Kazuyoshi Nakamura
Emiri Kita
Akiko Tsujimoto
Taketo Yamaguchi
机构：
[1] Chiba Cancer Center,Department of Gastroenterology
[2] Chiba Cancer Center,Department of Radiation Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2017年 / 80卷
关键词：
Pancreatic cancer; Gemcitabine; S-1; Chemoradiotherapy; Induction chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：195 / 202
页数：7
相关论文
共 50 条
  • [21] A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancer
    Saito, Kei
    Isayama, Hiroyuki
    Sakamoto, Yoshihiro
    Nakai, Yousuke
    Ishigaki, Kazunaga
    Tanaka, Mariko
    Watadani, Takeyuki
    Arita, Junichi
    Takahara, Naminatsu
    Mizuno, Suguru
    Kogure, Hirofumi
    Ijichi, Hideaki
    Tateishi, Keisuke
    Tada, Minoru
    Hasegawa, Kiyoshi
    Fukayama, Masashi
    Kokudo, Norihiro
    Koike, Kazuhiko
    MEDICAL ONCOLOGY, 2018, 35 (07)
  • [22] A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancer
    Kei Saito
    Hiroyuki Isayama
    Yoshihiro Sakamoto
    Yousuke Nakai
    Kazunaga Ishigaki
    Mariko Tanaka
    Takeyuki Watadani
    Junichi Arita
    Naminatsu Takahara
    Suguru Mizuno
    Hirofumi Kogure
    Hideaki Ijichi
    Keisuke Tateishi
    Minoru Tada
    Kiyoshi Hasegawa
    Masashi Fukayama
    Norihiro Kokudo
    Kazuhiko Koike
    Medical Oncology, 2018, 35
  • [23] Biweekly gemcitabine plus S-1 for locally advanced and metastatic pancreatic cancer: a preliminary feasibility study
    Wada, Keita
    Sano, Keiji
    Amano, Hodaka
    Miura, Fumihiko
    Toyota, Naoyuki
    Ito, Hiromichi
    Shibuya, Makoto
    Ikeda, Yutaka
    Kainuma, Masahiko
    Takada, Tadahiro
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2015, 22 (09) : 692 - 698
  • [24] A Phase I Study of S-1-based Concurrent Chemoradiotherapy Followed by Gemcitabine and S-1 in Metastatic Pancreatic Adenocarcinoma
    Yang, Shih-Hung
    Shao, Yu-Yun
    Lin, Chia-Chi
    Kuo, Sung-Hsin
    Cheng, Ann-Lii
    Yeh, Kun-Huei
    ANTICANCER RESEARCH, 2018, 38 (08) : 4805 - 4812
  • [25] Cost-effectiveness analysis of gemcitabine, S-1 and gemcitabine plus S-1 for treatment of advanced pancreatic cancer based on GEST study
    Jing Zhou
    Rongce Zhao
    Feng Wen
    Pengfei Zhang
    Ruilei Tang
    Zedong Du
    Xiaofeng He
    Jian Zhang
    Qiu Li
    Medical Oncology, 2015, 32
  • [26] Cost-effectiveness analysis of gemcitabine, S-1 and gemcitabine plus S-1 for treatment of advanced pancreatic cancer based on GEST study
    Zhou, Jing
    Zhao, Rongce
    Wen, Feng
    Zhang, Pengfei
    Tang, Ruilei
    Du, Zedong
    He, Xiaofeng
    Zhang, Jian
    Li, Qiu
    MEDICAL ONCOLOGY, 2015, 32 (04)
  • [27] A Multicenter Phase II Study of Gemcitabine plus S-1 Chemotherapy for Advanced Biliary Tract Cancer
    Arima, Shiho
    Shimizu, Kyoko
    Okamoto, Tomoyoshi
    Toki, Masao
    Suzuki, Yutaka
    Okano, Naohiro
    Naruge, Daisuke
    Kawai, Kirio
    Kobayashi, Takaaki
    Kasuga, Akiyoshi
    Kitamura, Hiroshi
    Takasu, Atuko
    Nagashima, Fumio
    Sugiyama, Masanori
    Furuse, Junji
    ANTICANCER RESEARCH, 2017, 37 (02) : 909 - 914
  • [28] Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer
    Jae-Sung Kim
    Joo Han Lim
    Jee Hyun Kim
    Seock-Ah Im
    Eui Kyu Chie
    Jin-Hyeok Hwang
    Tae-You Kim
    Yung-Jue Bang
    Sung Whan Ha
    Yong Bum Yoon
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 381 - 389
  • [29] Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer
    Kim, Jae-Sung
    Lim, Joo Han
    Kim, Jee Hyun
    Im, Seock-Ah
    Chie, Eui Kyu
    Hwang, Jin-Hyeok
    Kim, Tae-You
    Bang, Yung-Jue
    Ha, Sung Whan
    Yoon, Yong Bum
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (03) : 381 - 389
  • [30] Phase II trial of S-1 in combination with gemcitabine for chemo-na⟨ve patients with locally advanced or metastatic pancreatic cancer
    Lee, Gyeong-Won
    Kim, Hye Jung
    Ju, Ji-Hyun
    Kim, Seok-Hyun
    Kim, Hoon Gu
    Kim, Tae Hyo
    Kim, Hyun Jin
    Jeong, Chi-Young
    Kang, Jung Hun
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (04) : 707 - 713
12345